Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UBS AG filings for WUCT document foreign private issuer reporting and securities-offering disclosures for the ETRACS Whitney US Critical Technologies ETN. The record includes Form 6-K reports, Form 20-F references, IFRS consolidated financial information, capitalization disclosures, and debt and equity presentation for UBS AG and its subsidiaries.
Registration-related filings also incorporate Form F-3 materials and legal opinion exhibits for UBS AG securities offerings. These disclosures address the issuer's reporting framework, capital structure, funding from UBS Group AG, and the formal documentation supporting registered securities.
UBS AG is offering $340,500 in Trigger Autocallable Contingent Yield Notes linked to the common stock of Palantir Technologies Inc. (PLTR) maturing 28 June 2027. The unsecured, unsubordinated notes pay a contingent coupon of 23.30% p.a., but only for months in which Palantir’s closing share price is at or above the coupon barrier of $85.94 (60% of the $143.23 initial level). Each monthly observation date also carries an automatic call: if Palantir closes at or above the initial level, investors receive par plus the applicable coupon and the note terminates early.
If not called before the final valuation date (24 June 2027), principal is protected only when the final share price is at or above the downside threshold of $85.94. Otherwise, repayment is reduced one-for-one with Palantir’s decline, potentially to zero. Investors therefore face both equity market risk and UBS credit risk. The notes settle T+2, are not exchange-listed, and carry limited liquidity. UBS’s internal models assign an estimated initial value of $9.81 versus the $10 issue price, while the underwriting discount is $0.125 per note.
- Trade date: 24 June 2025; settlement: 26 June 2025
- Minimum investment: 100 notes ($1,000)
- CUSIP: 90309J495; ISIN: US90309J4958
- Proceeds to UBS: $9.875 per note after fees
Key risks highlighted include potential loss of principal, the possibility of receiving few or no coupons, dependence on UBS’s solvency, and an illiquid secondary market.